Published on
August 20, 2025
- 16:31 GMT
VIDA Extends Trial Imaging Platform with the Addition of Data-Driven Texture Analysis (DTA) Fibrosis Score for ILD
VIDA adds the extensively validated and widely published DTA Fibrosis Score to its suite of Interstitial Lung Disease (ILD) solutions CORALVILLE, IA, UNITED STATES, August 20, 2025 /EINPresswire.com/ -- VIDA Diagnostics, Inc. (VIDA), the leader in …
Distribution channels:
Healthcare & Pharmaceuticals Industry
...
